S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
The 3-Stock Retirement Blueprint (Ad)
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
Saudi Aramco's profits already $88B as oil prices stay high
Sell every Stock except ONE (Ad)
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
Average US gasoline price falls 45 cents to $4.10 per gallon
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
Sell every Stock except ONE (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
The 3-Stock Retirement Blueprint (Ad)
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
Saudi Aramco's profits already $88B as oil prices stay high
Sell every Stock except ONE (Ad)
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
Average US gasoline price falls 45 cents to $4.10 per gallon
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
Sell every Stock except ONE (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
The 3-Stock Retirement Blueprint (Ad)
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
Saudi Aramco's profits already $88B as oil prices stay high
Sell every Stock except ONE (Ad)
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
Average US gasoline price falls 45 cents to $4.10 per gallon
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
Sell every Stock except ONE (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
The 3-Stock Retirement Blueprint (Ad)
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
Saudi Aramco's profits already $88B as oil prices stay high
Sell every Stock except ONE (Ad)
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
Average US gasoline price falls 45 cents to $4.10 per gallon
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
Sell every Stock except ONE (Ad)
NASDAQ:ATNX

Athenex - ATNX News Headlines

$0.52
-0.02 (-3.70%)
(As of 08/12/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.52
$0.57
50-Day Range
$0.41
$1.11
52-Week Range
$0.41
$3.91
Volume
6.18 million shs
Average Volume
3.05 million shs
Market Capitalization
$63.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.00
Get Athenex News Delivered to You Automatically

Sign up to receive the latest news and ratings for ATNX and its competitors with MarketBeat's FREE daily newsletter.

ATNX Media Mentions By Week

ATNX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ATNX
News Sentiment

0.67

0.63

Average
Medical
News Sentiment

ATNX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ATNX Articles
This Week

17

3

ATNX Articles
Average Week



SourceHeadline
finance.yahoo.com logoAthenex, Inc. Announces Pricing of $30 Million Public Offering of Common Stock and Warrants - Yahoo Finance
finance.yahoo.com - August 13 at 10:08 PM
MarketBeat logoImmunoPrecise Antibodies (NASDAQ:IPA) vs. Athenex (NASDAQ:ATNX) Head to Head Survey
americanbankingnews.com - August 13 at 4:04 AM
seekingalpha.com logoAthenex (ATNX): Company Sale Is Likely To Be The Catalyst - Seeking Alpha
seekingalpha.com - August 11 at 7:05 PM
globenewswire.com logoAthenex, Inc. Announces Pricing of $30 Million Public Offering of Common Stock and Warrants - GlobeNewswire
globenewswire.com - August 11 at 2:05 PM
seekingalpha.com logoT2 Biosystems, Veru top healthcare gainers; Athenex, Invitae lead losers' pack - Seeking Alpha
seekingalpha.com - August 11 at 2:05 PM
finance.yahoo.com logoAthenex, Inc. Announces Pricing of $30 Million Public Offering of Common Stock and Warrants
finance.yahoo.com - August 11 at 2:04 PM
finance.yahoo.com logoDo Insiders Own Lots Of Shares In Athenex, Inc. (NASDAQ:ATNX)?
finance.yahoo.com - August 11 at 2:04 PM
seekingalpha.com logoAthenex stock slides on proposed securities offering (NASDAQ:ATNX) - Seeking Alpha
seekingalpha.com - August 10 at 4:47 PM
finance.yahoo.com logoAthenex, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Warrants
finance.yahoo.com - August 10 at 4:47 PM
nasdaq.com logoSelective Insurance Group (NASDAQ:SIGI) Could Be A Buy For Its Upcoming Dividend - Nasdaq
nasdaq.com - August 9 at 6:56 AM
nasdaq.com logoHere's What's Concerning About Addus HomeCare's (NASDAQ:ADUS) Returns On Capital - Nasdaq
nasdaq.com - August 8 at 8:52 PM
nasdaq.com logoEagle Bancorp Montana (NASDAQ:EBMT) Has Announced That It Will Be Increasing Its Dividend To $0.1375 - Nasdaq
nasdaq.com - August 8 at 8:52 PM
benzinga.com logoNasdaq Falls Over 100 Points, Marker Therapeutics Shares Spike Higher - Benzinga
benzinga.com - August 5 at 3:28 PM
investing.com logoPre-Open Movers: iRobot Surges on Amazon Takeover, Twilio Lower on Results By Investing.com - Investing.com
investing.com - August 5 at 3:28 PM
benzinga.com logoThumbs Down For Acadia's Antipsychotic Drug, Akebia Fails COVID-19 Study, Kazia's Encouraging Data In Bra - Benzinga
benzinga.com - August 5 at 3:28 PM
finance.yahoo.com logoIndia Based Pharma Companies In Race To Buy Athenex, Shares Surge
finance.yahoo.com - August 5 at 3:28 PM
seekingalpha.com logoATNX stock surges as Dr Reddy's and Intas race to buyout deal (NASDAQ:ATNX) - Seeking Alpha
seekingalpha.com - August 5 at 5:26 AM
finance.yahoo.com logoAlaunos Therapeutics Appoints Abhishek Srivastava, Ph.D. as Vice President, Technical Operations - Yahoo Finance
finance.yahoo.com - August 4 at 7:18 PM
investing.com logoAfter-Hours Movers: Cloudflare, DoorDash Gain on EPS; Warner Bros. Discovery Sinks By Investing.com - Investing.com
investing.com - August 4 at 7:18 PM
seekingalpha.com logoAthenex GAAP EPS, revenue misses estimates - Seeking Alpha
seekingalpha.com - July 29 at 5:14 AM
investing.com logoAthenex, Inc. Misses Q2 EPS by 13c By Investing.com - Investing.com
investing.com - July 28 at 2:11 PM
finance.yahoo.com logoAthenex (ATNX) Reports Q2 Loss, Lags Revenue Estimates
finance.yahoo.com - July 28 at 2:11 PM
benzinga.com logoRecap: Athenex Q2 Earnings - Benzinga
benzinga.com - July 28 at 9:05 AM
in.investing.com logoAthenex, Inc. Misses Q2 EPS by 13c By Investing.com - Investing.com India
in.investing.com - July 28 at 9:05 AM
finance.yahoo.com logoAthenex Provides Second Quarter 2022 Financial Results and Business Update - Yahoo Finance
finance.yahoo.com - July 28 at 9:05 AM
seekingalpha.com logoAthenex Q2 2022 Earnings Preview (NASDAQ:ATNX) - Seeking Alpha
seekingalpha.com - July 27 at 2:49 PM
benzinga.com logoAthenex Announces Publication Of Data From Phase 3 Study Comparing Oral Paclitaxel Plus Encequidar Versus - Benzinga
benzinga.com - July 25 at 10:27 PM
globenewswire.com logoAthenex Announces Publication of Data from Phase 3 Study Comparing Oral Paclitaxel Plus Encequidar Versus Intravenous Paclitaxel in Patients with Metastatic Breast Cancer in the Journal of Clinical Oncology - GlobeNewswire
globenewswire.com - July 25 at 12:25 PM
finance.yahoo.com logoAthenex Announces Publication of Data from Phase 3 Study Comparing Oral Paclitaxel Plus Encequidar Versus Intravenous Paclitaxel in Patients with Metastatic Breast Cancer in the Journal of Clinical Oncology
finance.yahoo.com - July 25 at 12:25 PM
globenewswire.com logoAthenex to Provide Corporate and Financial Update for the Second Quarter 2022 on July 28, 2022 - GlobeNewswire
globenewswire.com - July 21 at 3:34 PM
benzinga.com logoAthenex to Provide Corporate and Financial Update for the Second Quarter 2022 on July 28, 2022 - Benzinga - Benzinga
benzinga.com - July 21 at 3:34 PM
finance.yahoo.com logoAthenex to Provide Corporate and Financial Update for the Second Quarter 2022 on July 28, 2022
finance.yahoo.com - July 21 at 3:34 PM
benzinga.com logoAthenex Receives Notice Of Allowance For U.S. Patent Titled 'METHODS OF TREATING AND/OR PREVENTING ACTINI - Benzinga
benzinga.com - July 15 at 7:11 PM
globenewswire.com logoAthenex Announces Entry into Agreement to Sell its China API Business to TiHe Capital (Bejing) Co., Ltd. - GlobeNewswire
globenewswire.com - July 11 at 10:13 AM
finance.yahoo.com logoAthenex Announces Entry into Agreement to Sell its China API Business to TiHe Capital (Bejing) Co., Ltd.
finance.yahoo.com - July 11 at 10:13 AM
bizjournals.com logoShould therapeutics startups remain a focus in Buffalo? - Buffalo Business First - The Business Journals
bizjournals.com - July 1 at 6:57 AM
bizjournals.com logoImmunityBio's promise and challenges as it replaces Athenex in Dunkirk - Buffalo Business First - The Business Journals
bizjournals.com - June 30 at 10:55 AM
finance.yahoo.com logoAthenex to Participate in Truist Securities Cell Therapy Symposium - Yahoo Finance
finance.yahoo.com - June 23 at 10:08 PM
globenewswire.com logoAthenex to Participate in Truist Securities Cell Therapy Symposium - GlobeNewswire
globenewswire.com - June 23 at 5:07 PM
finance.yahoo.com logoAthenex to Participate in Truist Securities Cell Therapy Symposium
finance.yahoo.com - June 23 at 5:07 PM
finance.yahoo.com logoAthenex Announces Sale of Revenues from U.S. and European Royalty and Milestone Interests in Klisyri® (tirbanibulin) to Sagard Healthcare Partners and Oaktree
finance.yahoo.com - June 22 at 5:39 PM
streetinsider.com logoBioNJ Honors NJ's Innovators & the Patients Who Inspire Them - StreetInsider.com
streetinsider.com - June 14 at 5:54 PM
finance.yahoo.com logoAthenex Appoints Darrel P. Cohen, MD, PhD as Chief Medical Officer of Cell Therapy - Yahoo Finance
finance.yahoo.com - June 10 at 5:16 PM
finance.yahoo.com logoThe Global Throat Cancer Therapeutics Market is expected to grow by $ 1.82 bn during 2022-2026, accelerating at a CAGR of 6.7% during the forecast period - Yahoo Finance
finance.yahoo.com - June 10 at 7:15 AM
globenewswire.com logoAthenex Appoints Darrel P. Cohen, MD, PhD as Chief Medical Officer of Cell Therapy - GlobeNewswire
globenewswire.com - June 8 at 8:29 AM
finance.yahoo.com logoAthenex Appoints Darrel P. Cohen, MD, PhD as Chief Medical Officer of Cell Therapy
finance.yahoo.com - June 8 at 8:29 AM
finance.yahoo.com logoAthenex, Inc.'s (NASDAQ:ATNX) recent US$6.3m market cap decline means a loss of US$261k for insiders who bought this year
finance.yahoo.com - June 2 at 8:50 AM
globenewswire.com logoNorth America Compounding Pharmacies Market size to reach $7.8bn by 2026, says Graphical Research - GlobeNewswire
globenewswire.com - May 23 at 9:18 AM
finance.yahoo.com logoMerck, Athenex Join Forces To Evaluate Oraxol/Keytruda Combo In Lung Cancer
finance.yahoo.com - May 16 at 5:06 PM
seekingalpha.com logoMerck in pact to study Keytruda in combination with Athenex's lead asset (NASDAQ:ATNX) - Seeking Alpha
seekingalpha.com - May 16 at 9:19 AM
Get Athenex News Delivered to You Automatically

Sign up to receive the latest news and ratings for ATNX and its competitors with MarketBeat's FREE daily newsletter.

This page (NASDAQ:ATNX) was last updated on 8/14/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.